News You Can Use
Updates and news related to prostate cancer:
PSA Bounce
Understanding temporal fluctuations in prostate cancer after external radiotherapy
Testosterone Supplementation After Treatment for Localized Prostate Cancer
Early data has not demonstrated any increased risk of prostate cancer recurrence or progression in men using testosterone replacement therapy after prostate cancer.
The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer
It is important to consider disease volume, whether presentation with mCSPC is de novo, presence of comorbid conditions, and eligibility for docetaxel chemotherapy treatment.
Contemporary Prostate Cancer Radiation Therapy Trials
Do they underestimate the risk of biochemical recurrence?
PSMA-PET Shows Diagnostic Accuracy in Initial Staging of Prostate Cancer
Findings from a recent study show that PSMA-PET may have diagnostic value in the initial staging of patients with intermediate- and high-risk prostate cancer.
Prolaris’ Value in Predicting Prostate Cancer Outcomes
The National Comprehensive Cancer Network (NCCN) has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate cancer prognostication.
Role of Diet
Men on active surveillance who followed a low omega-6, high omega-3 diet with fish oil supplements had significantly lower levels of cancer cell proliferation after one year.
Use of Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
A VA study examines outcomes in patients.
Germline Testing
A study's implications for veteran access to prostate cancer treatments
Advances in Metastatic Castration Resistant Prostate Cancer Management
Recent approvals, emerging therapies, and future directions